MarketPeel
EVP R&D, Chief Medical Officer
Thu, Jan 30, 2025
Jan 30
sold $3.23m of ALKS
100,918 shares @ $32.05
Decreased holdings by -69.50%
4th largest trade (out of 157)
Planned (10b5-1)Large Trade
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 18% above 200-day moving average
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.23%
1M-7.60%
3M+28.30%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback